Primary hyperaldosteronism classification

Jump to: navigation, search


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]

Primary hyperaldosteronism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Primary Hyperaldosteronism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

CT scan Findings

MRI Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

Primary hyperaldosteronism classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Primary hyperaldosteronism classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Primary hyperaldosteronism classification

CDC on Primary hyperaldosteronism classification

Primary hyperaldosteronism classification in the news

Blogs on Primary hyperaldosteronism classification

Directions to Hospitals Treating Conn syndrome

Risk calculators and risk factors for Primary hyperaldosteronism classification

Overview

Primary hyperaldosteronism may be classified into five groups, including adrenal carcinoma, familial hyperaldosteronism type I and II, Idiopathic hyperaldosteronism (IH), primary adrenal hyperplasia, and aldosterone producing adenoma (APA), which is either renin-responsive or renin-unresponsive.

Classification

References

  1. Plouin, P.-F.; Amar, L.; Chatellier, G. (2004). "Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension". Nephrology Dialysis Transplantation. 19 (4): 774–777. doi:10.1093/ndt/gfh112. ISSN 0931-0509.
  2. Gordon, R.D. (1994). "Mineralocorticoid hypertension". The Lancet. 344 (8917): 240–243. doi:10.1016/S0140-6736(94)93003-1. ISSN 0140-6736.
  3. Phillips, John L.; Walther, McClellan M.; Pezzullo, John C.; Rayford, Walter; Choyke, Peter L.; Berman, Arlene A.; Linehan, W. Marston; Doppman, John L.; Gill Jr., John R. (2000). "Predictive Value of Preoperative Tests in Discriminating Bilateral Adrenal Hyperplasia from an Aldosterone-Producing Adrenal Adenoma". The Journal of Clinical Endocrinology & Metabolism. 85 (12): 4526–4533. doi:10.1210/jcem.85.12.7086. ISSN 0021-972X.



Linked-in.jpg